Add BrightSurf on Google Email

NF-κB signaling pathway: a central hub in the pathogenesis and therapeutic targeting of immunological diseases

The NF-κB signaling pathway plays a central role in pathogenesis and therapeutic targeting of immunological diseases. Dysregulation underpins many conditions, making it a crucial target for treatment. Emerging concepts like ubiquitin code editing and spatial immunology hold promise but require experimental validation.

SourceXia & He Publishing Inc.·JournalGene Expression·DateJul 13, 2026

A pilot clinical trial led by Germans Trias provides the first clinical proof of concept for ibuprofen as an adjunctive treatment for tuberculosis

A pilot clinical trial assessed ibuprofen's safety and efficacy as an adjunct to standard TB treatment in patients with pre-XDR-TB and XDR-TB. Participants showed a reduced inflammatory response, indicating potential benefits for host-directed therapies.

SourceGermans Trias i Pujol Research Institute·JournalNature Communications·TypeRandomized controlled/clinical trial·DateJul 13, 2026

Macrophages take center stage in organ transplantation: from chronic rejection mechanisms to targeted therapies

Macrophages are critical drivers of chronic allograft failure, with emerging strategies targeting key macrophage signaling pathways providing an important conceptual shift. Targeted therapies, such as inhibiting the purinergic pathway and mTOR/NF-κB pathway, show promise in preventing chronic rejection.

SourceImmunity & Inflammation·JournalImmunity & Inflammation·TypeSystematic review·DateJul 9, 2026

Gut bacteria linked to malnutrition may pass to younger generations

A new study found that specific gut bacteria from children with stunted growth can be passed to their offspring, causing inflammation and damage to the intestinal lining. The researchers identified Campylobacter concisus as a key contributor to this process, which may hold promise for future treatment and prevention strategies.

SourceWashU Medicine·JournalNature Microbiology·TypeExperimental study·DateJul 8, 2026

Study identifies a new cause of age-related inflammation, suggesting promising treatment pathway

A new study has identified a two-protein complex involved in exporting R-loops, which triggers an immune response causing harmful inflammation. The study tested an approved drug called KPT-330 and found significant improvements in inflammation, liver damage, fat gain, muscle loss, and lifespan in preclinical models.

Body clock found to control inflammatory responses in macrophages

Researchers from Kyushu University discovered that the circadian clock protein BMAL1 drives macrophages towards a pro-inflammatory M1 state by activating inflammatory signaling pathways. This mechanism links the body clock to intracellular metabolism and immune function, offering new insights into treating inflammatory diseases.

SourceKyushu University·JournalCell Reports·TypeExperimental study·DateJun 11, 2026

A study led by IGTP identifies a key mechanism regulating the anti-inflammatory function of extracellular vesicles

Researchers at IGTP identify N-glycosylation as essential for preserving immunomodulatory function of extracellular vesicles. The study found that intact N-glycosylation can reduce monocyte recruitment to inflamed endothelium, contributing to a better understanding of these vesicles' therapeutic potential.

SourceGermans Trias i Pujol Research Institute·JournalJournal of Extracellular Vesicles·TypeExperimental study·DateJun 9, 2026

Ethanol extracts of justicia carnea leaves mitigate pancreatic oxidative stress and preserve islet glucagon expression in TNBS-treated mice

This study found that Justicia carnea ethanol extracts effectively reduced oxidative stress markers, inflammation, and lipid peroxidation in a mouse model of chronic pancreatitis. The extracts also preserved islet glucagon expression, indicating potential therapeutic benefits for pancreatic damage.

SourceXia & He Publishing Inc.·JournalJournal of Exploratory Research in Pharmacology·DateMay 30, 2026

A study identifies the endocannabinoid system as a potential therapeutic target in severe acute pancreatitis

A study identified alterations in the endocannabinoid system associated with severe acute pancreatitis, including decreased circulating levels of 2-AG. Restoring 2-AG levels reduced inflammation and lung damage, highlighting the system's role in the disease's pathophysiology.

SourceGermans Trias i Pujol Research Institute·JournalThe Journal of Pathology·TypeExperimental study·DateMay 27, 2026

Senolytic drug combination delays early intervertebral disc degeneration in mice

Researchers developed a senolytic therapy using dasatinib and quercetin, which preserved disc structure and reduced inflammation, highlighting JUN signaling as a key pathway. This preclinical study provides evidence for a potential therapeutic strategy to slow disease progression in individuals with genetic susceptibility.

SourceEditorial Office of West China School of Stomatology, Sichuan University·JournalBone Research·TypeExperimental study·DateMay 25, 2026

Decoding Inflammatory Bowel Disease – on a chip

A new study replicated patient- and sex-specific hallmarks of Inflammatory Bowel Disease (IBD) in a human organ chip, identifying stromal fibroblasts as key drivers of inflammation, fibrosis, and enhanced cancer risk. The model also recapitulated the impact of pregnancy hormones on IBD severity in female patients.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalNature Biomedical Engineering·TypeExperimental study·DateMay 21, 2026

Researchers identify drivers of resistance to KRAS inhibitors in colorectal cancer

Researchers at UT MD Anderson Cancer Center have uncovered genetic and cell-state adaptive mechanisms that drive resistance to KRAS inhibitors in patients with KRAS-mutant colorectal cancer. Targeting early inflammatory responses by adding TBK1 blockade may be a promising combination strategy to overcome treatment resistance.

Disease-causing pathogen rewires gut metabolism to secure nutrients for growth: Study

Researchers at Vanderbilt University Medical Center discovered that enterotoxigenic Bacteroides fragilis reshapes intestinal cell metabolism to support its growth, causing diseases like diarrhea and colorectal cancer. The study provides new possibilities for intervention by targeting metabolic interactions between host and microbes.

SourceVanderbilt University Medical Center·JournalCell·TypeExperimental study·DateApr 30, 2026

Immune surveillance structures found in skin hair follicles

The study reveals that hair follicles contain specialized sentinel cells that monitor environmental exposure and microbial presence, potentially linking immune detection to sensory signaling. The discovery may have implications for understanding skin infections, immune disorders, and topical therapeutics.

SourceUniversity of California - Riverside·JournalFrontiers in Cell and Developmental Biology·TypeExperimental study·DateApr 24, 2026

Mapping the hidden triggers of jaw joint arthritis at the cellular level

A study mapped early molecular and cellular changes in the jaw joint that may trigger temporomandibular joint osteoarthritis. The research found structural and molecular changes in joint tissues, including inflammation, fibrosis, and metabolic shifts. Single-cell sequencing revealed diverse cell populations interacting within the synov...

SourceEditorial Office of West China School of Stomatology, Sichuan University·JournalInternational Journal of Oral Science·TypeExperimental study·DateApr 23, 2026

UMass Chan researchers shed light on how inflammation in GI tract rewires enteric nervous system

Research reveals inflammation in the GI tract changes how nerves are arranged, affecting intestinal muscle contractions. A protective stress response pathway helps neurons survive, preserving their structure and potentially offering a way to curtail persistent symptoms associated with IBD.

SourceUMass Chan Medical School·JournalJournal of Experimental Medicine·TypeExperimental study·DateApr 8, 2026

Novel treatment protocol developed at the University of Minnesota targets the deadliest cases of C. difficile infection

A new study from the University of Minnesota Medical School demonstrated that fecal microbiota transplantation (FMT) can rapidly reverse systemic inflammation and improve survival in patients with fulminant C. difficile infection. The treatment protocol achieved a 78% 30-day survival rate among 18 critically ill patients.

SourceUniversity of Minnesota Medical School·JournalClinical Gastroenterology and Hepatology·TypeData/statistical analysis·DateApr 6, 2026

New biomarker for immunoglobulin a nephropathy identified

Researchers have discovered a new biomarker for immunoglobulin A (IgA) nephropathy, which is an autoimmune disease that can lead to kidney failure. Complement pathway proteins, including CFHR1, were found to be overexpressed in patients with IgA nephropathy, suggesting a potential treatment target and diagnostic marker.

SourceFujita Health University·JournalScientific Reports·TypeExperimental study·DateMar 30, 2026

Engineered lipid nanoparticles reprogram immune metabolism for better mRNA vaccines

Researchers at the University of Pennsylvania developed lipid nanoparticles that modify immune metabolism to strengthen mRNA vaccines and reduce common side effects. The new lipid boosts the metabolism of immune cells, providing energy for the body's defenses while dialing down inflammatory signals.

SourceUniversity of Pennsylvania School of Engineering and Applied Science·JournalNature Materials·TypeExperimental study·DateMar 17, 2026